{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T03:59:26Z","timestamp":1786852766749,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ijpharm.2012.02.026","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T21:01:35Z","timestamp":1330030895000},"page":"76-82","source":"Crossref","is-referenced-by-count":16,"title":["Passive and iontophoretic transdermal delivery of phenobarbital: Implications in paediatric therapy"],"prefix":"10.1016","volume":"435","author":[{"given":"Asma","family":"Djabri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Bego\u00f1a","family":"Delgado-Charro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.02.026_bib0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/adc.2010.190330","article-title":"Prospective assessment of short-term propylene glycol tolerance in neonates","volume":"95","author":"Allagaert","year":"2010","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/jp.2011.116","article-title":"Update on the pharmacological management of neonatal abstinence syndrome","volume":"31","author":"Bio","year":"2011","journal-title":"J. Perinatol."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0883073808321056","article-title":"Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals","volume":"24","author":"Blume","year":"2009","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0020","unstructured":"BNF for children, 2010\u20132011. BMJ Group, Pharmaceutical Press, and RCPCH Publications Ltd., London."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0378-5173(93)90045-H","article-title":"In vitro percutaneous-absorption evaluation of phenobarbital through hairless mouse, adult and premature human skin","volume":"98","author":"Bonina","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00194954","article-title":"Determination of phenobarbitone population clearance values for South African children","volume":"48","author":"Botha","year":"1995","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2146\/ajhp060107","article-title":"Stability of an extemporaneously prepared alcohol-free phenobarbital suspension","volume":"64","author":"Cober","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/adc.67.1.152","article-title":"Treating neonatal jaundice with phenobarbitone: the inadvertent administration of significant doses of ethyl-alcohol","volume":"67","author":"Colquhoun-Flannery","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.18433\/J3201Z","article-title":"The tape-stripping technique as a method for drug quantification in skin","volume":"11","author":"Escobar-Chavez","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2003.10.025","article-title":"Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment","volume":"270","author":"Fang","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1600-0846.2009.00376.x","article-title":"Measuring transepidermal water loss: a comparative in vivo study of condenser-chamber, unventilated-chamber and open-chamber systems","volume":"15","author":"Farahmand","year":"2009","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0060","series-title":"Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice","first-page":"848","article-title":"Neonatal abstinence syndromes","author":"Finnegan","year":"2005"},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1600-0625.2006.00437.x","article-title":"Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models","volume":"15","author":"Fluhr","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0168-3659(92)90123-9","article-title":"In vitro and in vivo iontophoresis of a tripeptide across nude rat skin","volume":"20","author":"Green","year":"1992","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/adc.57.6.477","article-title":"Percutaneous alcohol absorption and skin necrosis in a preterm infant","volume":"57","author":"Harpin","year":"1982","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00607431","article-title":"Pharmacokinetics of pehnobarbital in childhood","volume":"12","author":"Heimann","year":"1977","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1523-1747.1998.00289.x","article-title":"Development of skin barrier function in premature infants","volume":"111","author":"Kalia","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1468-2494.2008.00476.x","article-title":"Closed-chamber transepidermal water loss measurement: microclimate, calibration and performance","volume":"31","author":"Imhof","year":"2009","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejps.2004.04.010","article-title":"Non-invasive monitoring of phenytoin by reverse iontophoresis","volume":"22","author":"Leboulanger","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0100","series-title":"Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice","first-page":"504","article-title":"Anticonvulsants","author":"Lehr","year":"2005"},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2004.11.035","article-title":"The correlation between transepidermal water loss and percutaneous absorption: An overview","volume":"103","author":"Levin","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0105","series-title":"The Merck Index","year":"2006"},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1023\/A:1018841111922","article-title":"Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil","volume":"16","author":"Merino","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jconrel.2005.12.020","article-title":"Prediction of iontophoretic transport across the skin","volume":"111","author":"Mudry","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0120","first-page":"1","article-title":"Sedatives for opiate withdrawal in newborn infants","volume":"10","author":"Osborn","year":"2010","journal-title":"Cochrane Libr."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/adc.57.9.653","article-title":"Phenobarbitone dosage in neonatal convulsions","volume":"57","author":"Ouvrier","year":"1982","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0169-409X(92)90022-I","article-title":"Transdermal ion migration","volume":"9","author":"Phipps","year":"1992","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0135","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-4632.2010.04819.x","article-title":"Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid","volume":"50","author":"Rubio","year":"2011","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0140","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/jps.20195","article-title":"Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss","volume":"93","author":"Sekkat","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0145","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1023\/B:PHAM.0000036912.94452.d0","article-title":"Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates","volume":"21","author":"Sekkat","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2008.07.002","article-title":"Iontophoresis of dexamethasone phosphate: competition with chloride ions","volume":"131","author":"Sylvestre","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0155","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2522\/ptj.20080043","article-title":"In vitro optimization of dexamethasone phosphate delivery by iontophoresis","volume":"88","author":"Sylvestre","year":"2008","journal-title":"Phys. Ther."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0928-0987(00)00145-7","article-title":"Clinical pharmacokinetics of phenobarbital in neonates","volume":"12","author":"Touw","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.026_bib0165","series-title":"Basic Clinical Pharmacokinetics","author":"Winter","year":"2010"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312001767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312001767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T22:24:46Z","timestamp":1543184686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312001767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0378517312001767"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.02.026","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}